Moneycontrol PRO
you are here: HomeNewsBusiness

Glenmark Pharmaceuticals to study potential COVID-19 drug combination

The study will look to enroll 158 hospitalized patients of moderate COVID-19 in India, the company added.

May 26, 2020 / 11:11 AM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Glenmark Pharmaceuticals Ltd said on Tuesday it will begin a new clinical trial in India to test a combination of two anti-viral drugs - favipiravir and umifenovir - as a potential COVID-19 treatment.

Coronavirus India LIVE News

The study will look to enroll 158 hospitalized patients of moderate COVID-19 in India, the company added.

Last month, Glenmark said it would conduct clinical trials in India of just favipiravir as a potential treatment for COVID-19.

Follow our full coverage of the coronavirus pandemic here.
Reuters